News

BI Innovator Awards Recipients
March 4, 2019

The inaugural 2019 BI Innovator Awards are awarded to Tim Bruns, Yichun Wang and Rose Cersonsky.

Read Story
The Shea group investitages antigen-conjugated nanoparticle treatment
UM Invests in BI Startup Greenmark Biomedical
February 22, 2019

Through the Michigan Investment in New Technology Startups (MINTS) initiative, UM will invest $500K in GreenMark Medical, a startup based on technologies developed by BI Director, Joerg Lahann.

Read Story
Steven Schwendeman
S. Schwendeman publishes collaborative research on long-active contraceptive delivery
January 21, 2019

A new publication from Steve Schwendeman and his collaborators from Georgia Tech appears in Nature Biomedical Engineering and features micro-needle patches for long-acting contraceptive delivery.

Read Story
BI Startup Evoq Therapeutics profiled in Crain’s Detroit
January 3, 2019

Crain’s Detroit features Evoq Therapeutics, a startup company co-founded by James Moon and Anna Schwendeman.

Read Story
Joerg Lahann
New Science article from the Lahann Lab
November 19, 2018

An article from the Lahann lab was recently published in Science. The article is entitled “Templated nanofiber synthesis via chemical vapor polymerization into liquid crystalline films” and reports on nanofiber arrays that can lead to various functional coatings.

Read Story
Sunitha Nagrath
Sunitha Nagrath wins ACS Award
October 22, 2018

Sunitha Nagrath is the recipient of the 2018 Analytical Chemistry Young Innovator Award. The award honors the contributions of an individual who has demonstrated exceptional technical advancement and innovation in the field of microfluidics or nanofluidics in his or her early career.

Read Story
Sunitha Nagrath
Sunitha Nagrath publishes work on new microfluidic Carpet Chip
October 3, 2018

The article entitled “Profiling Heterogeneous Circulating Tumor Cells (CTC) Populations in Pancreatic Cancer Using a Serial Microfluidic CTC Carpet Chip” appears in Advanced Biosystems.

Read Story
James Moon
James Moon Earns 2018 AAPS Emerging Leader Award
August 21, 2018

This award recognizes scientists and pharmaceutical professionals who are early in their careers, who have made a significant impact in the pharmaceutical sciences that promotes public health.

Read Story
Chestek, Moon and A. Schwendeman Promoted
May 21, 2018

Cindy Chestek (Biomedical Engineering), James Moon (Pharmaceutical Sciences) and A. Schwendeman (Pharmaceutical Sciences) were promoted to Associate Professor with tenure. Congratulations!

Read Story
Tessier elected to the AIMBE College of Fellows Class of 2018
May 3, 2018

Peter Tessier was elected a Fellow of the American Institute for Medical and Biological Engineering (AIMBE).  AIMBE comprises of leaders in medical and biological engineering, consisting of academic, industrial, professional society councils and elected fellows.

Read Story
Carlos Aguilar
Carlos Aguilar wins Non-Tenured Faculty Award from 3M
April 3, 2018

Carlos Aguilar is one of the recipients of the 2018 3M Non-Tenured Faculty Awards.  Awarded by 3M Corporation, this award recognizes junior faculty who demonstrate outstanding research, experience, teaching and academic leadership.

Read Story
Nanoparticle-based targeting and detection of microcavities
A. Schwendeman and S. Schwendeman publishes work in MAb
October 3, 2017

The article entitled “Biosimilarity under stress: A forced degradation study of Remicade® and Remsima™” appeared in MAb.

Read Story
Nanodiscs to delivery personalized cancer therapy
James Moon publishes work on a gold nanoparticle-based delivery platform
October 1, 2017

The article “Adjuvant-Loaded Spiky Gold Nanoparticles for Activation of Innate Immune Cells” appears in Cellular and Molecular Engineering.

Read Story
Deepak Nagrath
Nagrath identifying new cancer targets
September 25, 2017

In work started during his time at Rice University, Deepak Nagrath continues to research cancer cell metabolism and how cancer cells interact. Learning how the cells communicate could lead to new targets for more effective treatments than those currently is use.

Read Story
Labyrinth chip developed by Nagrath and Wicha used in clinical trial
Labyrinth chip developed by Nagrath and Wicha used in clinical trial
September 21, 2017

Currently being used in a breast cancer clinical trial to isolate cancer cells in blood, Sunitha Nagrath and Max Wicha led the development of a hydrodynamic maze called the labyrinth chip. With its innovative design, the labyrinth chip allows researchers to capture cells for molecular analysis so they can know what to target with treatments.

Read Story